Literature DB >> 16372390

Estimation of genetic and environmental factors for melanoma onset using population-based family data.

L Lindström1, Y Pawitan, M Reilly, K Hemminki, P Lichtenstein, K Czene.   

Abstract

Estimation of genetic and environmental contributions to cancers falls in the framework of generalized linear mixed modelling with several random effect components. Computational challenges remain, however, in dealing with binary or survival phenotypes. In this paper, we consider the analysis of melanoma onset in a population of 2.6 million nuclear families in Sweden, for which none of the current survival-based methodologies is feasible. We treat the disease outcome as a binary phenotype, so that the standard proportional hazard model leads to a generalized linear model with the complementary-log link function. For rare diseases this link is very close to the probit link, and thus allows the use of marginal likelihood for the estimation of the variance components. We correct for the survival length bias by censoring the parent generation within each family at the time they attain the same cumulative hazard as the child generation, thus improving the validity of the estimates. Our finding that childhood shared environment in addition to genetic factors had a considerable effect on the development of melanoma is consistent with epidemiological studies.

Entities:  

Mesh:

Year:  2006        PMID: 16372390     DOI: 10.1002/sim.2266

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  The familial risk of autism.

Authors:  Sven Sandin; Paul Lichtenstein; Ralf Kuja-Halkola; Henrik Larsson; Christina M Hultman; Abraham Reichenberg
Journal:  JAMA       Date:  2014-05-07       Impact factor: 56.272

2.  Maternal Effects as Causes of Risk for Obsessive-Compulsive Disorder.

Authors:  Behrang Mahjani; Lambertus Klei; Christina M Hultman; Henrik Larsson; Bernie Devlin; Joseph D Buxbaum; Sven Sandin; Dorothy E Grice
Journal:  Biol Psychiatry       Date:  2020-01-22       Impact factor: 13.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.